Flandina, C <br/><br/>
Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Dec 1996 
 - 465-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1120-009X 
<br/><br/><label>Standard No.: </label>10.1179/joc.1996.8.6.465  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Etoposide--pharmacology<br/>Humans<br/>Leukemia, T-Cell--metabolism<br/>Tumor Cells, Cultured--drug effects